Live Breaking News & Updates on Immune Therapies

Stay updated with breaking news from Immune therapies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AstraZeneca : Investor Day Biographies - MarketScreener

Investor Day 2024

Unlocking growth to 2030 and beyond

Speaker biographies

Pascal Soriot

. ....

United Kingdom , United States , Georgetown University , District Of Columbia , France General , Pascal Is , Sharon Barr , Anheuser Busch Inbev , Asia Pacific , Marc Dunoyer , Pascal Soriot , Roussel Uclaf , Dave Fredrickson , Roche Genentech , Hoechst Marion Roussel , Susan Galbraith , Iskra Reic , Andrew Barnett , Institute Of Marketing , Institute Of Cancer Research , Paris University , University Of London , World Economic Forum , Sustainable Markets Initiative , University Of Zagreb , University Of Delhi ,

AstraZeneca: positive results in Covid prevention

AstraZeneca announces that results from a Phase III pre-exposure prophylaxis trial against COVID-19 showed that AstraZeneca s sipavibart , an investigational long-acting antibody , demonstrated a. ....

Iskra Reic , Executive Vice President , Immune Therapies ,

AstraZeneca trials yield positive results for immunocompromised patients

AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

The Cambridge, England-based pharmaceutical company announced that phase three. ....

United Kingdom , Iskra Reic , Elijah Dale , Alliance News Ltd , Alliance News , Immune Therapies , All Rights ,

AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K

A6269o

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or. ....

United Kingdom , United States , Iskra Reic , Ghady Haidar , Adrian Kemp , Meerausw Immunocompromise , Health Database Study , Securities Exchange , Company On Social Media Astrazeneca , University Of Pittsburgh Medical Center , Large United States Commercial Insurance Health Plan , Forum Infect Dis , Investor Relations Team , Commission File Number , Company Secretary , Lancet Regional Health , Foreign Issuer , Securities Exchange Act , File Number , Crick Avenue , Regulationst Rule , Pittsburgh Medical Center , Executive Vice President , Immune Therapies , Rare Diseases , Social Media ,

AstraZeneca's Sipavibart shows promising results in COVID-19 prevention trial

AstraZeneca's sipavibart shows promising results in Phase III COVID-19 prevention trial for immunocompromised patients, reducing symptomatic cases significantly. A potential game-changer in protecting vulnerable populations. ....

Ghady Haidar , Iskra Reic , University Of Pittsburgh Medical Center , Astrazeneca Plc , Pittsburgh Medical Center , Executive Vice President , Immune Therapies ,